Form 4: Pacira BioSciences Director Acquires Shares and Stock Options
SEC Form 4 Filing
Director Marcelo Bigal acquired 5,230 shares of common stock and 12,179 stock options in Pacira BioSciences on June 12, 2024.
Summary
- On June 12, 2024, Marcelo Bigal, a director of Pacira BioSciences, acquired 5,230 shares of common stock.
- These shares were acquired at a price of $0.
- Following the transaction, Mr. Bigal directly owns 5,230 shares of Pacira BioSciences common stock.
- Mr. Bigal also acquired 12,179 stock options with an exercise price of $28.68.
- These options are exercisable from June 12, 2025, and expire on June 12, 2034.
- The restricted stock units vest on June 12, 2025, contingent upon continued service with the issuer.
Sentiment
Score: 6
Explanation: The sentiment is neutral to slightly positive. Insider buying can be a positive signal, but it's a single transaction and doesn't provide a comprehensive view of the company's health.
Positives
- The acquisition of shares and stock options by a director could be seen as a positive signal, indicating confidence in the company's future prospects.
Industry Context
Form 4 filings are standard practice and provide transparency into the transactions of company insiders, allowing investors to gauge management's sentiment and alignment with shareholder interests.
Stakeholder Impact
- Shareholders may view the director's stock purchase as a positive sign of confidence in the company's future.
Key Dates
| Date | Description |
|---|---|
| 06/12/2024 | Date of transaction: acquisition of common stock and stock options. |
| 06/12/2025 | Vesting date for restricted stock units, contingent upon continued service. |
| 06/12/2034 | Expiration date for the acquired stock options. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.